Abstract
A thorough understanding of normal prostate ultrasound anatomy is a prerequisite to the performance of effective prostate cryotherapy. Recommendations on optimization of imaging are provided, as well as suggestions to minimize injury to surrounding tissue. A comprehensive description of the pretreatment sonographic evaluation and operative techniques for primary and salvage prostate cryotherapy are included, with accompanying images. Possible applications of focal cryotherapy are explained. Oncologic outcomes data are discussed for primary, salvage, and focal prostate cryotherapy. The clinical utility of 3D transperineal mapping biopsies, with associated images, is provided. Finally, pitfalls resulting in incomplete ablation are explained, with comprehensive diagrams.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gage AA. History of cryosurgery. Semin Surg Oncol. 1998;14:99–109.
Babaian RJ, Donnelly B, Bahn D, Baust JG, Dineen M, Ellis D, et al. Best practice policy statement on cryosurgery for the treatment of localized prostate cancer. AUA clinical guidelines. J Urol. 2008;180(5):1993–2004.
Gage AA, Huben RP. Cryosurgical ablation of the prostate. Urol Oncol. 2000;5:11–9.
Cohen JK, Miller RR, Ahmed S, Lotz MJ, Baustaff J. Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology. 2008;71(3):515–8.
Chin JL, Al-Zahrani AA, Autran-Gomez AM, Williams AK, Bauman G. Extended followup oncologic outcome of randomized trial between cryoablation and external beam therapy for locally advanced prostate cancer (T2c-T3b). J Urol. 2012;188(4):1170–5.
Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002;60:3–11.
Dhar N, Ward JF, Cher ML, Jones JS. Primary full-gland prostate cryoablation in older men (>age of 75 years): results from 860 patients tracked with the COLD registry. Br J Urol Int. 2011;108:508–12.
Jones JS, Rewcastle JC, Donnelly BJ, Lugnani FM, Pisters LL, Katz AE. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008;180:554–8.
DiBlasio CJ, Derweesh IH, Malcolm JB, Maddox MM, Aleman MA, Wake RW. Contemporary analysis of erectile, voiding, and oncologic outcomes following primary targeted cryoablation of the prostate for clinically localized prostate cancer. Int Braz J Urol. 2008;34:443–50.
Donnelly BJ, Saliken JC, Brasher PM, Ernst SD, Rewcastle JC, Lau H, et al. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer. 2010;116:323–30.
Ellis DS, Manny TB, Rewcastle JC. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. Urology. 2007;69(2):306–10.
Han KR, Cohen JK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA, et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol. 2003;170(4):1126–30.
Hubosky SG, Fabrizio MD, Schellhammer PF, Barone BB, Tepera CM, Given RW. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life. J Endourol. 2007;21:1521–31.
Cresswell J, Asterling S, Chaudhary M, Sheikh N, Greene D. Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease. Br J Urol Int. 2006;97:969–74.
Wenske S, Quarrier S, Katz AE. Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery: long-term clinical, functional, and oncologic outcomes in a large cohort at a tertiary referral centre. Eur Urol. 2013;64:1–7.
Bahn DK, Lee F, Silverman P, Bahn E, Badalament R, Kumar A, et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer. 2003;2:111–4.
Pisters LL, Rewcastle JC, Donnelly BJ, Lugnani FM, Katz AE, Jones JS. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008;180:559–63.
Ghafar MA, Johnson CW, De La Taille A, Benson MC, Bagiella E, Fatal M, et al. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol. 2001;166:1333–7; discussion 1337–8.
Huang WC, Lee CL, Eastham JA. Locally ablative therapies for primary radiation failures: a review and critical assessment of the efficacy. Curr Urol Rep. 2007;8:217–23.
Gage AA, Baust JM, Baust JG. Experimental cryosurgery investigations in vivo. Cryobiology. 2009;59:229–43.
Klossner DP, Baust JM, VanBuskirk RG, Gage AA, Baust JG. Cryoablative response of prostate cancer cells is influenced by androgen receptor expression. Br J Urol Int. 2008;101(10):1310–6.
Williams AK, Martinez CH, Lu C, Ng CK, Pautler SE, Chin JL. Disease free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer. Eur Urol. 2011;60:405–10.
Ng CK, Moussa M, Downey DB, Chin JL. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome. J Urol. 2007;178:1253–7; discussion 1257.
Spiess PE, Katz AE, Chin JL, et al. A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer. Br J Urol Int. 2010;106:194–8.
Ismail M, Ahmed S, Kastner C, Davies J. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. Br J Urol Int. 2007;100:760–4.
Gowardhan B, Thomas B, Asterling S, Sheikh N, Greene DR. Cryosurgery for prostate cancer – experience with third-generation cryosurgery and novel developments in the field. Eur Urol Suppl. 2007;6:516–20.
Ward JF, Nakanishi H, Pisters L, et al. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy. Br J Urol Int. 2009;104:490–7.
Onik G, Barzell W. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol. 2008;26(5):506–10.
Onik G, Vaughan D, Lotenfoe R, et al. The “male lumpectomy”: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol. 2008;26(5):500–5.
Bahn D, de Castro Abreu AL, Gill IS, et al. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Eur Urol. 2012;62(1):55–63.
Ward JF, Jones JS. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry. BJU Int. 2012;109(11):1648–54.
Lambert EH, Bolte K, Masson P, et al. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology. 2007;69(6):1117–20.
Ellis DS, Manny Jr TB, Rewcastle JC. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Urology. 2007;70(6 Suppl):9–15.
Acknowledgment
The authors would like to thank Trina Orgain for her assistance with manuscript preparation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
McGinley, K.F., Polascik, B.W., Polascik, T.J. (2015). Ultrasound-Guided Prostate Cryotherapy. In: Liao, J., Su, LM. (eds) Advances in Image-Guided Urologic Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1450-0_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1450-0_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1449-4
Online ISBN: 978-1-4939-1450-0
eBook Packages: MedicineMedicine (R0)